Baird Medical Investment Holdings Limited Overview
Pro stress-test →Established in 2012 and headquartered in Guangzhou, China, Baird Medical is a leading microwave ablation (MWA) medical device manufacturer and provider in China. The company offers microwave ablation apparatus and needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps.
Strategic Profile
Pro stress-test →Baird Medical is the first company to obtain a Class III medical devices registration certificate for MWA medical devices specifically indicated for thyroid nodules in China. 2026 strategic priorities include accelerating U.S. commercial footprint and expanding adoption of minimally invasive Microwave Ablation thyroid technologies. The company has achieved regulatory approvals in markets such as Pakistan and Vietnam, and established a U.S. manufacturing base through a partnership with MPS Medical.
Competitive Landscape
Pro stress-test →Baird Medical operates in the niche minimally invasive thermal ablation market, competing with established medical device manufacturers. The company's focus on microwave ablation for thyroid and solid tumors differentiates it from radiofrequency and ultrasound alternatives. Competition includes larger global medical device companies expanding into ablation technologies.
Industry Context
Baird Medical Investment Holdings Limited operates in Medical Devices - Minimally Invasive Surgery / Thermal Ablation.
Key facts
Founded: 2012 · Headquarters: Guangzhou, China · Revenue: $37.04M · Market cap: $47.38M